chr8-109280976-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032869.4(NUDCD1):āc.1020G>Cā(p.Glu340Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,525,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032869.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NUDCD1 | NM_032869.4 | c.1020G>C | p.Glu340Asp | missense_variant | 6/10 | ENST00000239690.9 | |
NUDCD1 | NM_001128211.2 | c.933G>C | p.Glu311Asp | missense_variant | 6/10 | ||
NUDCD1 | XM_047422330.1 | c.759G>C | p.Glu253Asp | missense_variant | 6/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NUDCD1 | ENST00000239690.9 | c.1020G>C | p.Glu340Asp | missense_variant | 6/10 | 1 | NM_032869.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000331 AC: 8AN: 241730Hom.: 0 AF XY: 0.0000306 AC XY: 4AN XY: 130750
GnomAD4 exome AF: 0.00000510 AC: 7AN: 1373510Hom.: 0 Cov.: 23 AF XY: 0.00000583 AC XY: 4AN XY: 686242
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2023 | The c.1020G>C (p.E340D) alteration is located in exon 6 (coding exon 6) of the NUDCD1 gene. This alteration results from a G to C substitution at nucleotide position 1020, causing the glutamic acid (E) at amino acid position 340 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at